{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:20:13Z","timestamp":1768980013756,"version":"3.49.0"},"reference-count":81,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2007,8,15]],"date-time":"2007-08-15T00:00:00Z","timestamp":1187136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p><jats:list list-type=\"explicit-label\"><jats:list-item><jats:p>In atrium and ventricle from failing and non\u2010failing human hearts, activation of \u03b2<jats:sub>1<\/jats:sub>\u2010 or \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptors causes increases in contractile force, hastening of relaxation, protein kinase A\u2010catalysed phosphorylation of proteins implicated in the hastening of relaxation, phospholamban, troponin I and C\u2010protein, consistent with coupling of both \u03b2<jats:sub>1<\/jats:sub>\u2010 and \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptors to stimulatory G<jats:sub>sa<\/jats:sub>\u2010protein but not inhibitory G<jats:sub>ia<\/jats:sub>\u2010protein.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Two \u2018affinity states\u2019, namely \u03b2<jats:sub>1H<\/jats:sub>and \u03b2<jats:sub>1L<\/jats:sub>, of the \u03b2<jats:sub>1<\/jats:sub>\u2010adrenoceptor exist. In human heart, noradrenaline elicits powerful increases in contractile force and hastening of relaxation. These effects are blocked with high affinity by \u03b2\u2010adenoceptor antagonists, including propranolol, (\u2013)\u2010pindolol, (\u2013)\u2010CGP\u00a012177 and carvedilol. Some beta\u2010blockers, typified by (\u2013)\u2010pindolol and (\u2013)\u2010CGP\u00a012177, not only block the receptor, but also activate it, albeit at much higher concentrations (approximately 2 log units) than those required to antagonize the effects of catecholamines. In human heart, both (\u2013)\u2010CGP\u00a012177 and (\u2013)\u2010pindolol increase contractile force and hasten relaxation. However, the involvement of the \u03b2<jats:sub>1<\/jats:sub>\u2010adrenoceptor was not immediately obvious because (\u2013)\u2010pindolol\u2010 and (\u2013)\u2010CGP\u00a012177\u2010evoked responses were relatively resistant to blockade by (\u2013)\u2010propranolol. Abrogation of cardiostimulant effects of (\u2013)\u2010CGP\u00a012177 in \u03b2<jats:sub>1<\/jats:sub>\u2010\/\u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptor double\u2010knockout mice, but not \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptor\u2010knockout mice, revealed an obligatory role of the \u03b2<jats:sub>1<\/jats:sub>\u2010adrenoceptor. On the basis of these results, two \u2018affinity states\u2019 have been designated, the \u03b2<jats:sub>1H<\/jats:sub>\u2010 and \u03b2<jats:sub>1L<\/jats:sub>\u2010adrenoceptor, where the \u03b2<jats:sub>1H<\/jats:sub>\u2010adrenoceptor is activated by noradrenaline and blocked with high affinity by beta\u2010blockers and the \u03b2<jats:sub>1L<\/jats:sub>\u2010adrenoceptor is activated by drugs such as (\u2013)\u2010CGP\u00a012177 and (\u2013)\u2010pindolol and blocked with low affinity by beta\u2010blockers such as (\u2013)\u2010propranolol. The \u03b2<jats:sub>1H<\/jats:sub>\u2010 and \u03b2<jats:sub>1L<\/jats:sub>\u2010adrenoceptor states are consistent with high\u2010 and low\u2010affinity binding sites for (\u2013)\u2010[<jats:sup>3<\/jats:sup>H]\u2010CGP\u00a012177 radioligand binding found in cardiac muscle and recombinant \u03b2<jats:sub>1<\/jats:sub>\u2010adrenoceptors.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>There are two common polymorphic locations of the \u03b2<jats:sub>1<\/jats:sub>\u2010adrenoceptor, at amino acids 49 (Ser\/Gly) and 389 (Arg\/Gly). Their existence has raised several questions, including their role in determining the effectiveness of heart failure treatment with beta\u2010blockers. We have investigated the effect of long\u2010term maximally tolerated carvedilol administration (&gt;\u00a01 year) on left ventricular ejection fraction (LVEF) in patients with non\u2010ischaemic cardiomyopathy (mean left ventricular ejection fraction 23\u00a0\u00b1\u00a07%;<jats:italic>n<\/jats:italic>\u00a0=\u00a0135 patients). The administration of carvedilol improved LVEF to 37\u00a0\u00b1\u00a013% (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00.005); however, the improvement was variable, with 32% of patients showing \u00a3\u00a05% improvement. Upon segregation of patients into Arg389Gly\u2010\u03b2<jats:sub>1<\/jats:sub>\u2010adrenoceptors, it was found that carvedilol caused a greater increase in left ventricular ejection faction in patients carrying the Arg389 allele with Arg389Arg\u00a0&gt;\u00a0Arg389Gly\u00a0&gt;\u00a0Gly389Gly.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p>","DOI":"10.1111\/j.1440-1681.2007.04730.x","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T04:51:17Z","timestamp":1187326277000},"page":"1020-1028","source":"Crossref","is-referenced-by-count":35,"title":["HUMAN HEART \u03b2\u2010ADRENOCEPTORS: \u03b2<sub>1<\/sub>\u2010ADRENOCEPTOR DIVERSIFICATION THROUGH \u2018AFFINITY STATES\u2019 AND POLYMORPHISM"],"prefix":"10.1111","volume":"34","author":[{"given":"P","family":"Molenaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ABT","family":"Semmler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WA","family":"Parsonage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AJ","family":"Kaumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,15]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"crossref","unstructured":"KaumannAJ SandersL LynhamJAet al.\u03b22\u2010Adrenoceptor activation by zinterol causes protein phosphorylation contractile effects and relaxant effects through a cAMP pathway in human atrium.Mol. Cell. Biochem.1996;163\/164:113\u201323.","DOI":"10.1007\/BF00408647"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.1.65"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.15.1814"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-007-0138-x"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-003-0835-z"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15159.x"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-002-0652-9"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00004999"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1997.tb02107.x"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002100000336"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-57081-0_4"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(89)90065-5"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702936"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-004-0884-y"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.05.005"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.7.2197"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/mnc.2000.102678"},{"key":"e_1_2_10_19_2","unstructured":"MolenaarP ChenL MeyersEDet al.Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389\u2010 compared to GLY\u2010\u03b21\u2010adrenoceptor.Proc. Aust. Health Med. Res. Congr.2006;248(Abstract)."},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1987.tb11324.x"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1994.1040"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.66.6.1610"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02137-X"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.08.024"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00498852"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/10.suppl_B.29"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0700850"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.22.10798"},{"key":"e_1_2_10_29_2","doi-asserted-by":"crossref","first-page":"26\u00a0215","DOI":"10.1016\/S0021-9258(18)47181-5","article-title":"A proline\u2010rich region of the third intracellular loop imparts phenotypic \u03b21\u2010 versus \u03b22\u2010adrenergic receptor coupling and sequestration","volume":"269","author":"Green SA","year":"1994","journal-title":"J. Biol. Chem"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.52.33561"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.08.010"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(02)00851-1"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(83)91345-7"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4889(85)90090-4"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.79.6.1059"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2260113"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(90)81046-Q"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi980280j"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.17.8999"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-006-0119-5"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-007-0140-3"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00053-X"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706217"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001099900031"},{"key":"e_1_2_10_45_2","first-page":"322","article-title":"Functional coupling of the \u03b22\u2010adrenoceptor to a pertussis toxin\u2010sensitive G protein in cardiac myocytes","volume":"47","author":"Xiao R\u2010P","year":"1995","journal-title":"Mol. Pharmacol"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.84.1.43"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2005.04.006"},{"key":"e_1_2_10_48_2","doi-asserted-by":"crossref","first-page":"19\u00a0151","DOI":"10.1016\/S0021-9258(17)32287-1","article-title":"\u03b22\u2010Adrenergic receptor\u2010stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation","volume":"269","author":"Xiao R\u2010P","year":"1994","journal-title":"J. Biol. Chem"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00167383"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(92)93389-2"},{"key":"e_1_2_10_51_2","first-page":"221","article-title":"Field stimulation as a means of effecting the graded release of autonomic transmitters in isolated heart muscle","volume":"151","author":"Blinks JR","year":"1966","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_10_52_2","first-page":"63","article-title":"Cardiac \u03b2 receptors: Experimental aspects","volume":"72","author":"Kaumann AJ","year":"1983","journal-title":"Z. Kardiol"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.2610130604"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.3109\/10799899609039938"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.6.1312"},{"key":"e_1_2_10_56_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0026-895X(24)23196-5","article-title":"\u03b21\u2010Adrenergic receptors mediate \u03b23\u2010adrenergic\u2010independent effects of CGP\u00a012177 in brown adipose tissue","volume":"57","author":"Konkar AA","year":"2000","journal-title":"Mol. Pharmacol"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705420"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1986.tb11137.x"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704450"},{"key":"e_1_2_10_60_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.59.3.297"},{"key":"e_1_2_10_61_2","first-page":"203","article-title":"\u03b21\u2010 and \u03b22\u2010adrenoceptors in human heart: Properties, function and alterations in chronic heart failure","volume":"43","author":"Brodde O\u2010E.","year":"1991","journal-title":"Pharmacol. Rev"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702920"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.672"},{"key":"e_1_2_10_64_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6268.929"},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00568-2"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.11.1242"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.07.093"},{"key":"e_1_2_10_68_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.43.100901.135823"},{"key":"e_1_2_10_69_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020803"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1999.1994"},{"key":"e_1_2_10_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.04.012"},{"key":"e_1_2_10_72_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1999.0947"},{"key":"e_1_2_10_73_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2800"},{"key":"e_1_2_10_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605233342101"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105313442201"},{"key":"e_1_2_10_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92930-R"},{"key":"e_1_2_10_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"e_1_2_10_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"e_1_2_10_79_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.18.12670"},{"key":"e_1_2_10_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705753"},{"key":"e_1_2_10_81_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509937103"},{"key":"e_1_2_10_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm930"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2007.04730.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2007.04730.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T12:16:10Z","timestamp":1737375370000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2007.04730.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,15]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1440-1681.2007.04730.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2007.04730.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,15]]}}}